State of Wisconsin Investment Board’s Synergy Pharmaceuticals, Inc Common Stock SGYP Stock Holding History

State of Wisconsin Investment Board’s Portfolio SGYP Stock Details SGYP Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q1	–	Sell	-256,600	Closed	-$29K	–	1591
2018 Q4	$29K	Buy	256,600 +92,600	+56%	+$60.8K	﹤0.01%	1538
2018 Q3	$279K	Hold	164,000	–	–	﹤0.01%	1475
2018 Q2	$285K	Hold	164,000	–	–	﹤0.01%	1401
2018 Q1	$300K	Hold	164,000	–	–	﹤0.01%	1363
2017 Q4	$366K	Hold	164,000	–	–	﹤0.01%	1332
2017 Q3	$476K	Hold	164,000	–	–	﹤0.01%	1306
2017 Q2	$730K	Buy	+164,000	New	+$676K	﹤0.01%	1168

Other funds holding SGYP

TRCT

Tower Research Capital (TRC) New York $4.08B AUM 58.77% 1-Year Est. Return

State of Wisconsin Investment Board's SGYP Position: Q1 2019 in Review

State of Wisconsin Investment Board sold out of Synergy Pharmaceuticals, Inc Common Stock (SGYP) in Q1 2019, closing a stake of 256,600 shares — an estimated $29K sold.

State of Wisconsin Investment Board first reported a position in SGYP in Q2 2017 and held it in 7 quarters. The position peaked at $730K in Q2 2017. 12 funds tracked by Wall St. Rank hold SGYP as of Q1 2019.

State of Wisconsin Investment Board reported no remaining Synergy Pharmaceuticals, Inc Common Stock position as of Q1 2019 after selling out during the quarter.
State of Wisconsin Investment Board sold 256,600 Synergy Pharmaceuticals, Inc Common Stock shares in Q1 2019, an estimated $29K.
State of Wisconsin Investment Board first reported a position in Synergy Pharmaceuticals, Inc Common Stock in Q2 2017 and held it in 7 quarters.
State of Wisconsin Investment Board's Synergy Pharmaceuticals, Inc Common Stock position peaked at $730K in Q2 2017.
12 funds tracked by Wall St. Rank held Synergy Pharmaceuticals, Inc Common Stock as of Q1 2019.

Based on State of Wisconsin Investment Board's 13F filing for Q1 2019, filed 13 May 2019.